Pliant Therapeutics PLRX
NASDAQ PLRX
$0.79 -0.01 (-1.00%)
As of: Nov 10, 2026 · 12:56 PM EST

Pliant Therapeutics (PLRX) Net Long-Term Debt Issued (Repaid) (2022 - 2024)

Updated

Analysis

Pliant Therapeutics (PLRX) Net Long-Term Debt Issued (Repaid) (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Pliant Therapeutics 50.15 Mn -711.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1,000.00
Mar 31, 2024 19.91 Mn
Dec 31, 2022 -150,000.00
API Access

Pliant Therapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PLRX&period=max&api_key=YOUR_API_KEY